In vitro and in vivo studies of ocular topically administered NLC for the treatment of uveal melanoma.

Preliminary in vivo biodistribution images of fluorescent nanoparticles after topical instillation in rabbits' eyes, suggested their ability to reach the posterior segment of the eye, as a promising strategy for the treatment of choroidal uveal melanoma.